TCRX
USDTScan Therapeutics Inc. Common Stock
$1.120-0.050 (-4.274%)
Preço em tempo real
Healthcare
Biotecnologia
Estados Unidos
Gráfico de preços
Loading Chart...
Métricas-chave
Métricas de mercado
Abertura
$1.170
Máximo
$1.250
Mínimo
$1.080
Volume
0.81M
Fundamentos da empresa
Capitalização de mercado
63.6M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.51M
Bolsa de valores
NGM
Moeda
USD
Faixa de 52 semanas
Mínimo $1.02Atual $1.120Máximo $6.225
Notícias relacionadas
Analyst Upgrades
BTIG Downgrades TScan Therapeutics to Neutral
BTIG analyst Justin Zelin downgrades TScan Therapeutics from Buy to Neutral.
Ver mais
Analyst Upgrades
Needham Maintains Buy on TScan Therapeutics, Lowers Price Target to $6
Needham analyst Gil Blum maintains TScan Therapeutics with a Buy and lowers the price target from $9 to $6.
Ver mais
GlobeNewswire
TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
Positive end of Phase I meeting and agreement reached with FDA on pivotal study design for TSC-101 Dosed first solid tumor patients with multiplex TCR-T therapy; paused further enrollment to prioritize heme development;
Ver mais
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.